FDA-PUBLIC-HUMAN › Use of Public Human Genetic Variant Databases to Support Clinical Validity for Next Generation Sequencing (NGS)-Based In Vitro Diagnostics - Draft Guidance for Stakeholders and Food and Drug Administration Staff
Use of Public Human Genetic Variant Databases to Support Clinical Validity for Next Generation Sequencing (NGS)-Based In Vitro Diagnostics - Draft Guidance for Stakeholders and Food and Drug Administration Staff
This document comes with our free Notification Service, good for the life of the document.
This document is available in either Paper or PDF format.
Document Number
16008
Revision Level
2016 DRAFT
Status
Draft
Publication Date
July 8, 2016
Page Count
14 pages